Roman Butler Fullerton & Co. bought a new stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 17,185 shares of the pharmacy operator’s stock, valued at approximately $1,246,000. Walgreens Boots Alliance accounts for 1.1% of Roman Butler Fullerton & Co.’s holdings, making the stock its 18th biggest position.
Several other large investors also recently made changes to their positions in the stock. Parkside Investments LLC grew its position in shares of Walgreens Boots Alliance by 21.0% in the 4th quarter. Parkside Investments LLC now owns 37,914 shares of the pharmacy operator’s stock worth $2,590,000 after acquiring an additional 6,570 shares in the last quarter. Cambridge Trust Co. lifted its holdings in shares of Walgreens Boots Alliance by 11.6% in the 4th quarter. Cambridge Trust Co. now owns 7,670 shares of the pharmacy operator’s stock worth $524,000 after purchasing an additional 800 shares during the last quarter. Dearborn Partners LLC lifted its holdings in shares of Walgreens Boots Alliance by 1.3% in the 4th quarter. Dearborn Partners LLC now owns 224,627 shares of the pharmacy operator’s stock worth $15,349,000 after purchasing an additional 2,828 shares during the last quarter. Isthmus Partners LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $628,000. Finally, Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of Walgreens Boots Alliance by 276.8% in the 4th quarter. Patriot Financial Group Insurance Agency LLC now owns 3,195 shares of the pharmacy operator’s stock worth $218,000 after purchasing an additional 2,347 shares during the last quarter. Institutional investors and hedge funds own 66.57% of the company’s stock.
In related news, Director Nancy M. Schlichting sold 7,050 shares of the business’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total transaction of $555,610.50. Following the transaction, the director now directly owns 5,709 shares in the company, valued at $449,926.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.43 by $0.03. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The company had revenue of $33.79 billion during the quarter, compared to analysts’ expectations of $33.90 billion. During the same quarter in the previous year, the firm earned $1.28 earnings per share. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.52 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Friday, February 15th will be paid a dividend of $0.44 per share. The ex-dividend date is Thursday, February 14th. This represents a $1.76 annualized dividend and a yield of 2.46%. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
WBA has been the topic of several recent analyst reports. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Monday, November 26th. Morgan Stanley lifted their target price on Walgreens Boots Alliance from $55.00 to $77.00 and gave the company an “equal weight” rating in a research note on Monday, December 3rd. Goldman Sachs Group downgraded Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a research note on Friday, December 14th. BidaskClub downgraded Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 18th. Finally, Wolfe Research reissued a “peer perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, December 19th. Four analysts have rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $78.83.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.com-unik.info/2019/02/13/roman-butler-fullerton-co-takes-position-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.